Lack of Diversity in Cancer Clinical Trials: 2023 Best of Breast Conference

 

Dr Elyse Lower, MD from University of Cincinnati comments on the issue of underrepresentation of Black populations in cancer clinical trials: A need to diversify clinical trial populations as a means to understand disparate outcomes in breast cancer.

 
 

Related Resources

 
Previous
Previous

Recognizing the Role of the MDT in Breast Cancer Care: 2023 COEDS Ft Lauderdale Conference

Next
Next

Solving the Solvable Problem of Diversity in Clinical Trials: 2023 Best of Breast Conference